Mc Gaughy R Kent Jr Insider Trades

Insider Trading History

Track insider trading activity for Mc Gaughy R Kent Jr. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
10% owner
Holding Value $737k 4,275 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 4,275 shares
$93.61
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
10% owner
Holding Value $281k 1,628 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$152k 1,628 shares
$93.61
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Holding Value $0 0 shares
Last Trade
Mar 03, 2023 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$3.02M 33,217 shares
$90.87
$172.36
Procept BioRobotics
Procept BioRobotics PRCT
10% owner
Holding Value $272M 10,075,491 shares
Last Trade
Sep 06, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$31M 743,021 shares
$41.72
$27.00
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
10% owner
Holding Value $1.94M 11,240 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 11,240 shares
$34.76
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $1.94M 11,240 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 11,240 shares
$34.76
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
10% owner
Holding Value $825k 4,787 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 4,787 shares
$34.76
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Holding Value $68.8k 399 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9k 399 shares
$27.32
$172.36
Apollo Endosurgery
Apollo Endosurgery APEN
Director
Holding Value $5.22M 521,522 shares
Last Trade
Oct 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$300k 38,710 shares
$7.75
$10.00
Apollo Endosurgery
Apollo Endosurgery APEN
Director
Holding Value $21.5M 2,151,209 shares
Last Trade
Oct 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3M 387,097 shares
$7.75
$10.00
Apollo Endosurgery
Apollo Endosurgery APEN
10% owner
Holding Value $21.5M 2,151,209 shares
Last Trade
Oct 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3M 387,097 shares
$7.75
$10.00
Apollo Endosurgery
Apollo Endosurgery APEN
Director
Holding Value $6.96M 696,071 shares
Last Trade
Oct 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2M 258,064 shares
$7.75
$10.00
Apollo Endosurgery
Apollo Endosurgery APEN
10% owner
Holding Value $6.96M 696,071 shares
Last Trade
Oct 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2M 258,064 shares
$7.75
$10.00
Apollo Endosurgery
Apollo Endosurgery APEN
10% owner
Holding Value $5.22M 521,522 shares
Last Trade
Oct 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$300k 38,710 shares
$7.75
$10.00
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
10% owner
Holding Value $119k 690 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$101k 690 shares
$146.01
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
10% owner
Holding Value $862k 5,000 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$730k 5,000 shares
$146.01
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Holding Value $499M 2,896,901 shares
Last Trade
Dec 23, 2020 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$21.2M 166,666 shares
$127.15
$172.36
Apollo Endosurgery
Apollo Endosurgery APEN
10% owner
Holding Value $4.15M 415,244 shares
Last Trade
Jul 17, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$564k 400,000 shares
$1.41
$10.00
Apollo Endosurgery
Apollo Endosurgery APEN
10% owner
Holding Value $17.1M 1,707,208 shares
Last Trade
Jul 17, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.69M 1,200,000 shares
$1.41
$10.00
Apollo Endosurgery
Apollo Endosurgery APEN
10% owner
Holding Value $4.77M 477,120 shares
Last Trade
Jul 17, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$254k 180,000 shares
$1.41
$10.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up